LIPID TESTING, LIPID MODIFYING THERAPY AND PCSK9 INHIBITOR ELIGIBILITY IN 22,603 PATIENTS WITH INCIDENT ACUTE CORONARY SYNDROME
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI